Susan Hutchinson
Adult Medicine · Laguna Hills, CANPI 1386739795
Payments from drug & device makers
Across 1,677 payments — averaging $599.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$325K
- Lilly USA, LLC$228K
- Amgen$123K
- Teva Pharmaceuticals USA, Inc.$73K
- Lundbeck LLC$72K
- Biohaven Pharmaceuticals, Inc.$57K
- plus $129K from 27 others
Across 6 payments — averaging $1206.67 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$6K
- Eli Lilly$1K
What the payments were for
- Consulting fees$254,10425%
- Speaking & faculty fees$680,19968%
- Grants$850%
- Travel & lodging$41,1154%
- Food & beverage$29,4653%
- Education$2190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 525 | $325,166 |
| Lilly USA, LLC | 421 | $227,684 |
| Amgen | 167 | $122,817 |
| Teva Pharmaceuticals USA, Inc. | 85 | $72,577 |
| Lundbeck LLC | 113 | $71,576 |
| Biohaven Pharmaceuticals, Inc. | 97 | $56,704 |
| Upsher-smith Laboratories LLC | 41 | $23,399 |
| Axsome Therapeutics, Inc. | 25 | $20,961 |
| Biohaven Pharmaceutical Holding Company Ltd. | 33 | $20,750 |
| Impel Pharmaceuticals Inc. | 18 | $13,792 |
| Scilex Pharmaceuticals Inc. | 10 | $9,762 |
| Currax Pharmaceuticals LLC | 13 | $9,179 |
| Pfizer | 15 | $8,665 |
| Promius Pharma LLC | 16 | $8,330 |
| Astellas Pharma US Inc | 4 | $4,698 |
| Novartis | 11 | $2,781 |
| Biodelivery Sciences International, Inc. | 2 | $2,504 |
| Amneal Pharmaceuticals LLC | 6 | $2,103 |
| Supernus Pharmaceuticals, Inc. | 38 | $410 |
| Bausch Health US, LLC | 4 | $315 |
| Eli Lilly | 4 | $232 |
| Avanir Pharmaceuticals, Inc. | 1 | $225 |
| Assertio Therapeutics, Inc. | 6 | $107 |
| Zyla Life Sciences, Inc. | 5 | $83 |
| Alfasigma USA, Inc. | 3 | $68 |
| Curonix LLC | 1 | $64 |
| Eisai Inc. | 3 | $59 |
| Tersera Therapeutics LLC | 2 | $44 |
| Almatica Pharma LLC | 3 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $39 |
| GSK | 1 | $29 |
| GE HealthCare | 1 | $13 |
| Collegium Pharmaceutical, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- UBRELVY$249,688
- AIMOVIG$122,661
- EMGALITY$97,754
- NURTEC ODT$83,940
- AJOVY$71,698
- VYEPTI$69,679
- REYVOW$58,751
- QULIPTA$40,407
- BOTOX$21,272
- Symbravo$15,940
- Trudhesa$13,599
- ELYXYB - CELECOXIB$12,241
- Tosymra Sumatriptan Nasal Spray$9,811
- ZEMBRACE SYMTOUCH$8,691
- ONZETRA XSAIL$6,125
- TOSYMRA$6,062
- Zembrace SymTouch Sumatriptan Injection$5,648
- Veozah$4,611
- ZAVZPRET$3,700
- QUDEXY XR Topiramate Extended Release Capsules$3,200
How this compares
$1,005,187 in reported general payments places this provider in the 95th percentile of 221 adult medicine providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sumatriptan Succinate | 23 | $120 |
Paid to pharmacies, not to this prescriber.
Other adult medicine in Laguna Hills
- Gary BooneSan Diego$4.9M
- Salil NadkarniWest Hollywood$3.3M
- Robert FerreraSacramento$2.6M
- Ramin FarsadEncinitas$2.2M
- Natalia GuzmanLos Angeles$583K
- Yasuko KidokoroSan Diego$267K
- Richard FauselRancho Mirage$30K
- Benedicto EstoestaValley Springs$22K
- Antoine DipsiaW. Sacramento$21K
- Patrick WelchArroyo Grande$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.